会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • Novel cancer-associated gene
    • 新型癌症相关基因
    • US20060275302A1
    • 2006-12-07
    • US10535733
    • 2003-11-20
    • Osamu OharaTakahiro NagaseReiko KikunoShin-ichi Funahashi
    • Osamu OharaTakahiro NagaseReiko KikunoShin-ichi Funahashi
    • A61K39/395C07H21/04C12P21/06C07K14/82C07K16/30
    • C12N9/1048C07K14/4748
    • The present invention provides: a novel DNA, a carcinoma-associated gene comprising the DNA, a recombinant protein encoded by the DNA, an antibody binding to the protein, an anti-carcinoma agent comprising the antibody, a low-molecular-weight compound binding to the protein, and a screening system. An example of such a novel DNA is a DNA comprising a nucleotide sequence encoding the following polypeptide (a) or (b): (a) a polypeptide, consisting of an amino acid sequence identical to or substantially identical to the amino acid sequence represented by SEQ ID NO: 2; or (b) a polypeptide, consisting of an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO: 2 by deletion, substitution, or addition of one or a plurality of amino acids and having biological activity substantially equivalent to the functions of the polypeptide (a).
    • 本发明提供:新型DNA,包含DNA的癌相关基因,由DNA编码的重组蛋白,与蛋白结合的抗体,包含抗体的抗癌剂,结合 蛋白质和筛选系统。 这样的新型DNA的实例是包含编码以下多肽(a)或(b)的核苷酸序列的DNA:(a)多肽,由与氨基酸序列相同或基本相同的氨基酸序列组成, SEQ ID NO:2; 或(b)通过缺失,取代或添加一个或多个氨基酸并具有与功能基本相同的生物学活性的由SEQ ID NO:2所示的氨基酸序列衍生的氨基酸序列组成的多肽 的多肽(a)。
    • 4. 发明授权
    • Synthetic peptide derivatives and the salts thereof
    • 合成肽衍生物及其盐
    • US5908828A
    • 1999-06-01
    • US497599
    • 1995-06-30
    • Takashi KuritaTomoaki MatsumotoReiko KikunoYoko Otawara-HamamotoGerhard Breipohl
    • Takashi KuritaTomoaki MatsumotoReiko KikunoYoko Otawara-HamamotoGerhard Breipohl
    • A61K38/00C07K14/51A61K38/16C07K14/00
    • C07K14/51A61K38/00
    • The present invention provides synthetic peptide derivatives represented by the formulaP.sup.1 -R.sup.1 -P.sup.2wherein P.sup.1 is a peptide having an amino acid sequence in the SEQ ID NO.:1 of the Sequence Listing, or analogues thereof; P.sup.2 is a peptide having an amino acid sequence in the SEQ ID NO.:2 of the Sequence Listing, or analogues thereof; R.sup.1 denotes a linker with a property that does not interfere with the activity of the each peptide P.sup.1 and P.sup.2 to bind N-terminal end of the peptides P.sup.1 and P.sup.2.The present invention also provides a pharmaceutical composition for the treatment of bone related diseases comprising said peptide derivatives, or a therapeutically acceptable salt thereof, and a pharmaceutically acceptable carrier.The present invention also provides a method of treating bone related diseases in a mammal comprising administering thereto an effective amount of said peptide derivatives, or therapeutically acceptable salts thereof.
    • 本发明提供由式P1-R1-P2表示的合成肽衍生物,其中P1是具有序列表SEQ ID NO:1中的氨基酸序列的肽或其类似物; P2是具有序列表的SEQ ID NO:2中的氨基酸序列的肽或其类似物; R1表示具有不影响各肽P1和P2与肽P1和P2的N末端结合的活性的性质的连接体。 本发明还提供了用于治疗骨相关疾病的药物组合物,其包含所述肽衍生物或其治疗上可接受的盐和药学上可接受的载体。 本发明还提供了治疗哺乳动物中骨相关疾病的方法,其包括向其施用有效量的所述肽衍生物或其可治疗可接受的盐。
    • 5. 发明授权
    • Cancer-associated gene
    • 癌症相关基因
    • US07790866B2
    • 2010-09-07
    • US10535733
    • 2003-11-20
    • Osamu OharaTakahiro NagaseReiko KikunoShin-ichi Funahashi
    • Osamu OharaTakahiro NagaseReiko KikunoShin-ichi Funahashi
    • C07H21/02C07H21/04C07K14/00C07K17/00C12P21/06C12P19/34C12N15/64
    • C12N9/1048C07K14/4748
    • The present invention provides: a novel DNA, a carcinoma-associated gene comprising the DNA, a recombinant protein encoded by the DNA, an antibody binding to the protein, an anti-carcinoma agent comprising the antibody, a low-molecular-weight compound binding to the protein, and a screening system. An example of such a novel DNA is a DNA comprising a nucleotide sequence encoding the following polypeptide (a) or (b): (a) a polypeptide, consisting of an amino acid sequence identical to or substantially identical to the amino acid sequence represented by SEQ ID NO: 2; or (b) a polypeptide, consisting of an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO: 2 by deletion, substitution, or addition of one or a plurality of amino acids and having biological activity substantially equivalent to the functions of the polypeptide (a).
    • 本发明提供:新型DNA,包含DNA的癌相关基因,由DNA编码的重组蛋白,与蛋白结合的抗体,包含抗体的抗癌剂,结合 蛋白质和筛选系统。 这样的新型DNA的实例是包含编码以下多肽(a)或(b)的核苷酸序列的DNA:(a)多肽,由与氨基酸序列相同或基本相同的氨基酸序列组成, SEQ ID NO:2; 或(b)通过缺失,取代或添加一个或多个氨基酸并具有与功能基本相同的生物学活性的由SEQ ID NO:2所示的氨基酸序列衍生的氨基酸序列组成的多肽 的多肽(a)。
    • 6. 发明申请
    • Novel genes and proteins encoded thereby
    • 由此编码的新型基因和蛋白质
    • US20060160082A1
    • 2006-07-20
    • US10530880
    • 2003-10-16
    • Osamu OharaTakahiro NagaseReiko Kikuno
    • Osamu OharaTakahiro NagaseReiko Kikuno
    • C12Q1/68C07H21/02C12P21/06C07K14/705C07K16/28
    • C07K14/47
    • A novel DNA comprising a protein-encoding region is directly cloned from cDNA library originating from human adult whole brain and human fetal whole brain, the base sequence thereof is determined, and the functions thereof are identified. A DNA comprising a base sequence encoding the following polypeptide (a) or (b): (a) a polypeptide consisting of an amino acid sequence which is identical or substantially identical with the amino acid sequence represented by SEQ ID No.1, (b) a polypeptide consisting of an amino acid sequence represented by SEQ ID No.1 in which part of amino acids are deleted, substituted or added, and having substantially the same biological activity as the function of the polypeptide (a), recombinant polypeptide encoded by the above DNAs, and protein comprising the polypeptide.
    • 从源自人成人全脑和人胎儿全脑的cDNA文库直接克隆包含蛋白质编码区的新型DNA,确定其碱基序列,鉴定其功能。 包含编码以下多肽(a)或(b)的碱基序列的DNA:(a)由与SEQ ID No.1所代表的氨基酸序列相同或基本相同的氨基酸序列组成的多肽 )由SEQ ID No.1所示的氨基酸序列组成的多肽,其中部分氨基酸缺失,取代或添加,并且具有与多肽(a)的功能基本上相同的生物学活性,由 上述DNA和包含该多肽的蛋白质。